Sands Capital Management LLC Acquires 11,279 Shares of McKesson Corporation $MCK

Sands Capital Management LLC raised its stake in shares of McKesson Corporation (NYSE:MCK) by 7.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 157,146 shares of the company’s stock after acquiring an additional 11,279 shares during the period. Sands Capital Management LLC owned approximately 0.13% of McKesson worth $121,402,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in MCK. Brighton Jones LLC lifted its position in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares during the period. Caxton Associates LLP bought a new stake in McKesson in the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC lifted its holdings in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after buying an additional 300 shares during the period. Penserra Capital Management LLC boosted its stake in shares of McKesson by 8.5% in the 2nd quarter. Penserra Capital Management LLC now owns 690 shares of the company’s stock worth $504,000 after buying an additional 54 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of McKesson by 5,743.6% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 28,809 shares of the company’s stock worth $21,111,000 after acquiring an additional 28,316 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

Shares of MCK stock opened at $928.60 on Wednesday. The stock has a market cap of $113.74 billion, a PE ratio of 26.71, a price-to-earnings-growth ratio of 1.52 and a beta of 0.38. The stock has a 50-day moving average of $886.79 and a 200-day moving average of $820.88. McKesson Corporation has a one year low of $635.00 and a one year high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the previous year, the company earned $8.03 earnings per share. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Michele Lau sold 2,725 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. The trade was a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 in the last three months. 0.08% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on MCK shares. Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Leerink Partners reiterated an “outperform” rating and issued a $1,085.00 price objective on shares of McKesson in a research note on Thursday, March 5th. Mizuho boosted their target price on shares of McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. TD Cowen lifted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Barclays upped their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 18th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.